The design of new
biomolecules able to harness immune
mechanisms
for the treatment of diseases is a prime challenge for computational
and simulative approaches. For instance, in recent years, antibodies
have emerged as an important class of therapeutics against a spectrum
of pathologies. In cancer, immune-inspired approaches are witnessing
a surge thanks to a better understanding of tumor-associated antigens
and the mechanisms of their engagement or evasion from the human immune
system. Here, we provide a summary of the main state-of-the-art computational
approaches that are used to design antibodies and antigens, and in
parallel, we review key methodologies for epitope identification for
both B- and T-cell mediated responses. A special focus is devoted
to the description of structure- and physics-based models, privileged
over purely sequence-based approaches. We discuss the implications
of novel methods in engineering biomolecules with tailored immunological
properties for possible therapeutic uses. Finally, we highlight the
extraordinary challenges and opportunities presented by the possible
integration of structure- and physics-based methods with emerging
Artificial Intelligence technologies for the prediction and design
of novel antigens, epitopes, and antibodies.